Literature DB >> 2088576

Location of disulfide bonds in antithrombin III.

Z R Zhou1, D L Smith.   

Abstract

Proteolytic digests of human antithrombin III (ATIII) have been analyzed by a combination of reversed-phase high-performance liquid chromatography and fast atom bombardment (FAB) mass spectrometry for disulfide-containing peptides which are diagnostic for disulfide linkages in ATIII. These results indicate that disulfide bonds join Cys 8 and Cys 128, Cys 21 and Cys 95, and Cys 247 and Cys 430. In addition, these results demonstrate that systematic searches of the amino acid sequence of a large protein for segments with molecular weights matching FAB mass spectral information is a viable method for identifying peptides independent of the specificity of the enzyme used to fragment the protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088576     DOI: 10.1002/bms.1200191206

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  4 in total

1.  Assignment of a single disulphide bridge in human alpha2-antiplasmin: implications for the structural and functional properties.

Authors:  S Christensen; Z Valnickova; I B Thogersen; E H Olsen; J J Enghild
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

2.  Disulfide structures of highly bridged peptides: a new strategy for analysis.

Authors:  W R Gray
Journal:  Protein Sci       Date:  1993-10       Impact factor: 6.725

3.  Automated data interpretation based on the concept of "negative signature mass" for mass-mapping disulfide structures of cystinyl proteins.

Authors:  Jianfeng Qi; Wei Wu; Chad R Borges; Dehua Hang; Matthew Rupp; Eric Torng; J Throck Watson
Journal:  J Am Soc Mass Spectrom       Date:  2003-09       Impact factor: 3.109

4.  Proper secretion of the serpin antithrombin relies strictly on thiol-dependent quality control.

Authors:  Benjamin M Adams; Haiping Ke; Lila M Gierasch; Anne Gershenson; Daniel N Hebert
Journal:  J Biol Chem       Date:  2019-10-29       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.